FDA still deciding on wether to approve Ella in the U.S. - KCBD NewsChannel 11 Lubbock

6/17/10

FDA still deciding on wether to approve Ella in the U.S.

Posted:

By Karin McCay| email

Edited by Kristin Beerman | email 

LUBBOCK, TX (KCBD) – An advisory panel to the Food and Drug Administration has recommended a new prescription "morning after" pill, saying it is safe and effective.  The drug, called Ella one, was found in studies of nearly 5,000 women to prevent pregnancy for up to five days after unprotected sex, which is two days longer than Plan B, the drug currently on the market in the U.S.  Ella one is already approved in 22 European countries.

The studies found nearly 70% of expected pregnancies were prevented in women taking the pill. The most common side effects were headache, nausea, abdominal pain and fatigue.  The drug works by blocking the hormone progesterone, which tells the ovaries to release an egg and also lines the uterus in preparation for implantation.

Anti-abortion groups are concerned that this might cause an abortion in women who don't know they're already pregnant. The FDA review didn't draw a definitive conclusion on the effect of Ella one on established pregnancies. Supporters say the extra time provided by this drug will give women more options. For more information please go to www.fda.gov.

©2010 KCBD NewsChannel 11.  All rights reserved.  This material may not be published, broadcast, rewritten, or redistributed.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.